// App-Quantinova.ai

: Subcutaneous Isatuximab Administration By an on-Body Delivery System (OBDS) in Combination with Pomalidomide and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: Phase 1b Expansion Study Results

Researchers

Presenter

  • Hang Quach

Principal Investigators

  • Gurdeep Parmar

  • Enrique M. Ocio

  • H. Miles Prince

  • Albert Oriol

  • Nobuhiro Tsukada

  • Kazutaka Sunami

  • Pierre Bories

  • Sumit Madan

  • Dorothee Semiond

  • Disa Yu

  • Sandrine Mace

  • Florence Suzan

  • Philippe Moreau

Medical Centers

  • Institut Català d'Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain

  • Molecular Oncology and Cancer Immunology, Epworth Healthcare and University of Melbourne, Melbourne, Australia

  • Illawarra Cancer Care Centre, Wollongong, Australia

  • Banner MD Anderson Cancer Center at Banner University Medical Center, Phoenix, AZ

  • Early Phase Unit, Institut Claudius Regaud, Institut Universitaire du Cancer Toulouse, Toulhouse, France

  • Department of Clinical Haematology, St Vincent's Hospital, University of Melbourne, Melbourne, Australia

  • University Hospital Marqués de Valdecilla (IDIVAL), University of Cantabria, Santander, Spain

  • Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan

  • Hematology Department, University Hospital Hôtel-Dieu, Nantes, France

  • Department of Hematology, National Hospital Organization Okayama Medical Center, Okayama, Japan

Locations

  • Spain

  • Japan

  • Australia

  • United States

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • Cluster of Differentiation 38

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Pomalidomide

  • CC-4047

  • Isatuximab

Outcome

  • N/A

Study Design

  • Randomized

  • Safety

  • Pharmacokinetics

  • Open Label

  • Multicenteric

  • Expansion Study

  • Cohort

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved